Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of potent receptor modulators, especially for neurological and psychiatric disorders such as depression, anxiety, and schizophrenia. The presence of the trifluoroacetyl group enhances metabolic stability and influences binding affinity in final drug molecules. Commonly utilized in medicinal chemistry for constructing piperidine-based bioactive molecules with improved pharmacokinetic profiles.